Form 4: Lucid Diagnostics Director Jacque J. Sokolov Acquires 112,800 Shares of Restricted Stock

Director Jacque J. Sokolov acquired 112,800 shares of Lucid Diagnostics restricted stock on February 20, 2025, under the Issuer's 2018 Equity Plan.

Summary

• On February 20, 2025, Jacque J. Sokolov, a director of Lucid Diagnostics Inc., acquired 112,800 shares of common stock.
• The acquisition was in the form of restricted stock granted under the company's 2018 Equity Plan.
• The restricted stock vests on May 20, 2028, and is subject to forfeiture if the required service period is not completed.
• Following the transaction, Sokolov directly owns 197,460 shares of Lucid Diagnostics Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of restricted stock aligns the director's interests with the long-term success of the company.

Risks

• The restricted stock is subject to forfeiture if the service period is not completed, which could impact the director's holdings.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of a director's stock ownership and changes in ownership, which is common in publicly traded companies. It reflects standard practice for aligning management and shareholder interests through equity compensation.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment as it indicates insider confidence.

Key Dates

Keywords

Lucid Diagnostics, Director, Jacque J. Sokolov, Restricted Stock, Equity Plan, Beneficial Ownership, Form 4